Table 2. Summarized statistics of the association between WDR5 gene expression and breast cancer patient survival.
| Data set | Subgroup | P | HR | Sample |
|---|---|---|---|---|
| GSE24450 | Main | 0.008 | 2.74 | 183 (39) |
| GSE1456 | Main | 0.034 | 1.98 | 159 (40) |
| GSE4922 | Main | 0.059 | 1.56 | 249 (89) |
| GSE24450 | Anthr+ | 0.003 | 5.25 | 68 (18) |
| GSE24450 | Anthr- | 0.651 | 0.60 | 23 (9) |
The p value and hazard ratio (HR) of tumours over-expressing WDR5 are depicted below. In the ‘Subgroup’ column, ‘Anthr+’ and ‘Anthr-’ labels represent the anthracycline treated and untreated group respectively, and ‘main’ means all samples are used in the analysis. The number of patients is shown in the ‘Sample’ column, with the number of events listed in the brackets.